Masashi Shimura

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmaceutical statistics

Statistics in medicine

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, an Irreversible FGFR1-4 Inhibitor: Pooled Safety analysis of 469 patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Masashi Shimura, Kazushi Maruo, Masahiko Gosho
Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early. Pharmaceutical statistics 17 (5) (2018)
Masashi Shimura
Reducing overestimation of the treatment effect by interim analysis when designing clinical trials. Journal of clinical pharmacy and therapeutics 44 (2) (2018)
Masashi Shimura, Masahiko Gosho, Akihiro Hirakawa
Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data. Statistics in medicine 36 (13) (2017)